Wang, Zhuo <br/><br/>
Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.  [electronic resource] 

 -  Cell death & disease  04 2018 
 - 613 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/s41419-018-0573-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II<br/>Animals<br/>Collagen--metabolism<br/>Dipeptides--metabolism<br/>Disease Models, Animal<br/>Fibrosis<br/>GTP-Binding Proteins--antagonists & inhibitors<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>Mice<br/>Myocardium--pathology<br/>Myofibroblasts--drug effects<br/>Protein Glutamine gamma Glutamyltransferase 2<br/>Small Molecule Libraries--pharmacology<br/>Transforming Growth Factor beta1--pharmacology<br/>Transglutaminases--antagonists & inhibitors